Paradigm Capital Cuts Merus Labs International Inc (MSL) Price Target to C$1.60
Merus Labs International Inc (TSE:MSL) had its price objective lowered by Paradigm Capital from C$1.75 to C$1.60 in a research report released on Tuesday. The brokerage currently has a hold rating on the specialty pharmaceutical company’s stock.
Several other research firms have also issued reports on MSL. Scotiabank cut their price target on Merus Labs International from C$2.25 to C$1.75 and set a sector perform rating for the company in a report on Tuesday, August 16th. CIBC cut their price target on Merus Labs International from C$2.90 to C$2.50 in a report on Tuesday, August 16th. TD Securities reissued a buy rating and set a C$4.00 price target on shares of Merus Labs International in a report on Tuesday, August 16th. Finally, Canaccord Genuity cut their price target on Merus Labs International from C$4.25 to C$3.50 and set a buy rating for the company in a report on Tuesday, August 16th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of C$2.77.
Shares of Merus Labs International (TSE:MSL) opened at 1.33 on Tuesday. The company’s 50-day moving average price is $1.33 and its 200-day moving average price is $1.64. The stock’s market cap is $155.61 million. Merus Labs International has a one year low of $1.18 and a one year high of $2.40.
About Merus Labs International
Merus Labs International Inc (Merus) is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products in Canada and internationally. It carries out business principally in Canada and Europe. The Company has products in the area of urology/women’s health and anti-infectives.
Receive News & Ratings for Merus Labs International Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International Inc and related companies with MarketBeat.com's FREE daily email newsletter.